p53 may positively regulate hepatocyte proliferation in rats

Levin, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 Prives, 1999, The p53 pathway, J Pathol, 187, 112, 10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3 Shin, 1995, p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53, Mol Cell Biol, 15, 4694, 10.1128/MCB.15.9.4694 Deb, 1994, Wild-type human p53 activates the human epidermal growth factor receptor promoter, Oncogene, 9, 1341 Ludes-Meyers, 1996, Transcriptional activation of the human epidermal growth factor receptor promoter by human p53, Mol Cell Biol, 16, 6009, 10.1128/MCB.16.11.6009 Sheikh, 1997, Identification of an additional p53-responsive site in the human epidermal growth factor receptor gene promotor, Oncogene, 15, 1095, 10.1038/sj.onc.1201264 Metcalfe, 1997, Wild-type but not mutant p53 activates the hepatocyte growth factor/scatter factor promoter, Nucl Acids Res, 25, 983, 10.1093/nar/25.5.983 Thompson, 1986, Sequential protooncogene expression during rat liver regeneration, Cancer Research, 46, 3111 Fausto, 1996, Hepatology, 1, 32 Michalopoulos, 1990, Liver regeneration: molecular mechanisms of growth control, FASEB J, 4, 176, 10.1096/fasebj.4.2.2404819 Zarnegar, 1994, Liver: Biology and Pathology, 1047 Tsubouchi, 1999, Hepatocyte growth factor for liver disease, Hepatology, 30, 333, 10.1002/hep.510300149 Ishiki, 1992, Direct evidence that hepatocyte growth factor is a hepatotropic factor for liver regeneration and has a potent antihepatitis effect in vivo, Hepatology, 16, 1227 Fujiwara, 1993, Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats, Hepatology, 18, 1443, 10.1016/0270-9139(93)90237-H Derynck, 1988, Transforming growth α, Cell, 54, 593, 10.1016/S0092-8674(88)80001-1 Mead, 1989, Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism, Proc Natl Acad Sci U S A, 86, 1558, 10.1073/pnas.86.5.1558 Webber, 1993, Transforming growth factor-α expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-α and hepatocyte growth factor, Hepatology, 18, 1422, 10.1002/hep.1840180622 Webber, 1994, In vivo response of hepatocytes to growth factors requires an initial priming stimulus, Hepatology, 19, 489, 10.1002/hep.1840190230 Liu, 1994, Collagenase pretreatment and mitogenic effects of hepatocyte growth factor and transforming growth factor-α in adult rat liver, Hepatology, 19, 1521, 10.1002/hep.1840190630 Tomiya, 1998, Transforming growth factor α levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration, Am J Pathol, 153, 955, 10.1016/S0002-9440(10)65637-4 Tomiya, 1993, Serum levels of transforming growth factor-α in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay, Hepatology, 18, 304, 10.1002/hep.1840180213 Tomiya, 1992, Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients, Gastroenterology, 103, 1621, 10.1016/0016-5085(92)91186-8 Tomiya, 1997, Serum transforming growth factor α level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer, Semin Oncol, 24, 14 Tomiya, 1996, Fujiwara K. Liver regeneration in fulminant hepatitis as evaluated by serum transforming growth factor α levels, Hepatology, 23, 253 Tomiya, 1992, Significance of serum human hepatocyte growth factor levels in patients with hepatic failure, Hepatology, 15, 1, 10.1002/hep.1840150102 Tomiya, 2000, The mitogenic activity of hepatocyte growth factor on rat hepatocytes is dependent upon endogenous tranforming growth factor α, Am J Pathol, 157, 1693, 10.1016/S0002-9440(10)64806-7 Stolz,, 1994, Comparative effects of hepatocyte growth factor and epidermal growth factor on motility, morphology, mitogenesis and signal transduction of primary rat hepatocytes, J Cell Biochem, 55, 445, 10.1002/jcb.240550405 Presnell, 1997, Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-α in rat liver epithelial cells, Mol Carcinog, 18, 244, 10.1002/(SICI)1098-2744(199704)18:4<244::AID-MC8>3.0.CO;2-D Komarov, 1999, A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy, Science, 285, 1733, 10.1126/science.285.5434.1733 Hirota, 1996, p53 antisense oligonucleotide inhibits growth of human colon tumor and normal cell lines, Jpn J Cancer Res, 87, 735, 10.1111/j.1349-7006.1996.tb00286.x Messmer, 1996, Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways, Biochem J, 319, 299, 10.1042/bj3190299 Ceraline, 1998, Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents, Int J Cancer, 75, 432, 10.1002/(SICI)1097-0215(19980130)75:3<432::AID-IJC17>3.0.CO;2-A Katoh, 1990, Detection of transforming growth factor alpha in human urine and plasma, Biochem Biophys Res Commun, 167, 1065, 10.1016/0006-291X(90)90631-V Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing principle of protein-dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Seglen, 1976, Preparation of isolated rat liver cells, Methods Cell Biol, 13, 29, 10.1016/S0091-679X(08)61797-5 da Costa, 2002, Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons, Proc Natl Acad Sci U S A, 99, 4043, 10.1073/pnas.062059899 Milne, 1994, Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases, J Biol Chem, 269, 9253, 10.1016/S0021-9258(17)37101-6 Faletto, 1993, Signal transduction in c-met mediated motogenesis, EXS, 65, 107 Pulverer, 1991, Phosphorylation of c-jun mediated by MAP kinases, Nature, 353, 670, 10.1038/353670a0 Seth, 1992, Signal transduction within the nucleus by mitogen-activated protein kinase, J Biol Chem, 267, 24796, 10.1016/S0021-9258(18)35834-4 Shivakumar, 1995, Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter, Mol Cell Biol, 15, 6785, 10.1128/MCB.15.12.6785 Lennartsson, 1999, p53 expression and TGF-alpha-induced replication of hepatocytes isolated from rats exposed to the carcinogen diethylnitrosamine, Cell Biol Toxicol, 15, 31, 10.1023/A:1007598522366 Kubbutat, 1997, Regulation of p53 stability by Mdm2, Nature, 387, 299, 10.1038/387299a0 Haupt, 1997, Mdm2 promotes the rapid degradation of p53, Nature, 387, 296, 10.1038/387296a0 Bellamy, 1997, p53 Deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage, FASEB J, 11, 591, 10.1096/fasebj.11.7.9212083 Donehower, 1992, Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours, Nature, 356, 215, 10.1038/356215a0 Arora, 2000, c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activity, J Pharmacol Exp Ther, 292, 921 Arora, 2000, Antisense oligonucleotides targeted to the p53 gene modulate liver regeneration in vivo, Drug Metab Dispos, 28, 131 Albrecht, 1997, Regulation of cyclin-dependent kinase inhibitor p21 (WAF1/Cip1/Sdi1) gene expression in hepatic regeneration, Hepatology, 25, 557, 10.1002/hep.510250311